Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enaltus
Suwanee, Georgia, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Enaltus offers FDA-listed, commercialized topical, silicone-based scar and skincare therapies (e.g., Kelo-cote, bioCorneum+, Belli Skincare) widely marketed in the US and globally; the company is not engaged in traditional drug clinical trials[1][2][4].
- Therapeutic areas
- OtherDermatology
- Modalities
- Topical medical gelEmollient sprayTopical cream
- Industry
- Therapeutic Medical Devices
02
Partnerships
Capriclear (Skin Evolution, LLC, co-promotion/licensing)Celazome (Dermazone Solution, Inc., licensing)Hydrosal (Valeo Pharma, Inc., licensing)Arnika Forte, Hydro-Q (DermAvance, licensing)Prutect (Prugen, Inc., licensing)
Beyond the preview
Go deeper on Enaltus.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Enaltus.